Esperion Therapeutics Statistics
Total Valuation
ESPR has a market cap or net worth of $805.76 million. The enterprise value is $1.19 billion.
Important Dates
The last earnings date was Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ESPR has 257.43 million shares outstanding. The number of shares has increased by 14.32% in one year.
| Current Share Class | 257.43M |
| Shares Outstanding | 257.43M |
| Shares Change (YoY) | +14.32% |
| Shares Change (QoQ) | -11.67% |
| Owned by Insiders (%) | 0.85% |
| Owned by Institutions (%) | 68.28% |
| Float | 255.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.93 |
| Forward PS | 2.22 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.85 |
| EV / EBITDA | 15.72 |
| EV / EBIT | 15.75 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.53
| Current Ratio | 1.53 |
| Quick Ratio | 0.96 |
| Debt / Equity | n/a |
| Debt / EBITDA | 6.94 |
| Debt / FCF | n/a |
| Interest Coverage | 0.89 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 12.04% |
| Return on Invested Capital (ROIC) | 23.47% |
| Return on Capital Employed (ROCE) | 46.73% |
| Weighted Average Cost of Capital (WACC) | 11.02% |
| Revenue Per Employee | $1.42M |
| Profits Per Employee | -$25,248 |
| Employee Count | 294 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 1.37 |
Taxes
In the past 12 months, ESPR has paid $1.84 million in taxes.
| Income Tax | 1.84M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +179.46% in the last 52 weeks. The beta is 1.07, so ESPR's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | +179.46% |
| 50-Day Moving Average | 2.68 |
| 200-Day Moving Average | 2.98 |
| Relative Strength Index (RSI) | 70.21 |
| Average Volume (20 Days) | 10,655,902 |
Short Selling Information
The latest short interest is 20.21 million, so 7.85% of the outstanding shares have been sold short.
| Short Interest | 20.21M |
| Short Previous Month | 36.43M |
| Short % of Shares Out | 7.85% |
| Short % of Float | 7.92% |
| Short Ratio (days to cover) | 1.02 |
Income Statement
In the last 12 months, ESPR had revenue of $418.24 million and -$7.42 million in losses. Loss per share was -$0.03.
| Revenue | 418.24M |
| Gross Profit | 241.70M |
| Operating Income | 75.79M |
| Pretax Income | -5.58M |
| Net Income | -7.42M |
| EBITDA | 75.89M |
| EBIT | 75.79M |
| Loss Per Share | -$0.03 |
Full Income StatementBalance Sheet
The company has $156.16 million in cash and $543.81 million in debt, with a net cash position of -$387.65 million or -$1.51 per share.
| Cash & Cash Equivalents | 156.16M |
| Total Debt | 543.81M |
| Net Cash | -387.65M |
| Net Cash Per Share | -$1.51 |
| Equity (Book Value) | -307.93M |
| Book Value Per Share | -1.20 |
| Working Capital | 159.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$18.19 million and capital expenditures -$189,000, giving a free cash flow of -$18.38 million.
| Operating Cash Flow | -18.19M |
| Capital Expenditures | -189,000 |
| Depreciation & Amortization | 106,000 |
| Net Borrowing | -54.91M |
| Free Cash Flow | -18.38M |
| FCF Per Share | -$0.07 |
Full Cash Flow StatementMargins
Gross margin is 57.79%, with operating and profit margins of 18.12% and -1.77%.
| Gross Margin | 57.79% |
| Operating Margin | 18.12% |
| Pretax Margin | -1.33% |
| Profit Margin | -1.77% |
| EBITDA Margin | 18.15% |
| EBIT Margin | 18.12% |
| FCF Margin | n/a |
Dividends & Yields
ESPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.32% |
| Shareholder Yield | -14.32% |
| Earnings Yield | -0.92% |
| FCF Yield | -2.28% |
Analyst Forecast
The average price target for ESPR is $3.19, which is 1.92% higher than the current price. The consensus rating is "Hold".
| Price Target | $3.19 |
| Price Target Difference | 1.92% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 12.04% |
| EPS Growth Forecast (3Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ESPR has an Altman Z-Score of -2.72 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.72 |
| Piotroski F-Score | 5 |
